- Home
- TERN vs RWAY Comparison
TERN vs RWAY Comparison
Compare TERN & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- RWAY
- Stock Information
- Founded
- TERN 2017
- RWAY 2015
- Country
- TERN United States
- RWAY United States
- Employees
- TERN N/A
- RWAY N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- RWAY
- Sector
- TERN Health Care
- RWAY
- Exchange
- TERN Nasdaq
- RWAY Nasdaq
- Market Cap
- TERN 495.2M
- RWAY 410.4M
- IPO Year
- TERN 2021
- RWAY 2021
- Fundamental
- Price
- TERN $7.06
- RWAY $10.91
- Analyst Decision
- TERN Buy
- RWAY Buy
- Analyst Count
- TERN 5
- RWAY 6
- Target Price
- TERN $15.63
- RWAY $11.00
- AVG Volume (30 Days)
- TERN 1.1M
- RWAY 272.5K
- Earning Date
- TERN 08-05-2025
- RWAY 08-07-2025
- Dividend Yield
- TERN N/A
- RWAY 13.54%
- EPS Growth
- TERN N/A
- RWAY 153.06
- EPS
- TERN N/A
- RWAY 1.91
- Revenue
- TERN N/A
- RWAY $140,975,000.00
- Revenue This Year
- TERN N/A
- RWAY N/A
- Revenue Next Year
- TERN N/A
- RWAY N/A
- P/E Ratio
- TERN N/A
- RWAY $5.71
- Revenue Growth
- TERN N/A
- RWAY N/A
- 52 Week Low
- TERN $1.87
- RWAY $8.35
- 52 Week High
- TERN $11.40
- RWAY $11.73
- Technical
- Relative Strength Index (RSI)
- TERN 71.76
- RWAY 53.12
- Support Level
- TERN $6.43
- RWAY $10.79
- Resistance Level
- TERN $6.34
- RWAY $11.20
- Average True Range (ATR)
- TERN 0.42
- RWAY 0.20
- MACD
- TERN 0.04
- RWAY -0.01
- Stochastic Oscillator
- TERN 98.68
- RWAY 63.01
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States.